The State of AI in Precision Oncology
Hosted by AI in Precision Oncology
Artificial Intelligence (AI) is profoundly changing the practice of medicine in general and oncology in particular. As the new Sage journal AI in Precision Oncology documents in every issue, clinicians are increasingly deploying a host of AI applications and strategies to transform their practice, personalize treatments and save patient lives.
Now in its third year, The State of AI in Precision Oncology virtual summit has established itself as one of the premier venues to discuss the evolution of medicine thanks to AI. For this year’s event, founding Editor-in-Chief Doug Flora, MD, and colleagues have recruited an outstanding selection of renowned physicians, entrepreneurs, and AI thought leaders to assess the state of AI in the field of precision oncology through a series of keynote interviews, presentations and fireside chats.
Among the brilliant talent speaking in this year’s summit are:
- Amy Abernethy, MD, PhD, chair of the International Advisory Board of Health Data Research UK, and a former executive with Flatiron Health, Verily, and the FDA.
- Isaac Kohane, MD, PhD, inaugural chair of the Department of Biomedical Informatics at Harvard Medical School and the founding editor of NEJM AI, in a must-watch conversation with his editorial peer, Doug Flora, MD.
- Connie Lehman, MD, PhD, an acclaimed radiologist at Mass General Hospital/Harvard Medical School, and founder of Clairity, on the use of AI in breast cancer screening.
- Betsy O’Donnell, MD, on advances in blood-based cancer screening using advanced data analysis.
- Lucio Gordan, MD, on the state of AI in cancer community hospitals.
- And David Penberthy, MD, caps off the summit by exploring the state of “AI in Oncology 2030”.
The Editors of AI in Precision Oncology extend a warm welcome to the journal's third annual virtual summit: The State of AI in Precision Oncology.
Please join us on December 16. Registration is free!